France· FR:61715282
PONVORY 2 mg + 3 mg + 4 mg + 5 mg + 6 mg + 7 mg + 8 mg + 9 mg + 10 mg, comprimé pelliculé
A medicinal product containing ponésimod, registered in France by LABORATOIRES JUVISE PHARMACEUTICALS, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- PONÉSIMOD
- Manufacturer
- LABORATOIRES JUVISE PHARMACEUTICALS
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip133400930232231plaquette(s) thermoformée(s) OPA : polyamide orienté aluminium polyéthylène polytéréphtalate (PET) - Pack d’initiation 14 comprimés (2 x 2 mg + 2 x 3 mg + 2 x 4 mg + 1 x 5 mg + 1 x 6 mg + 1 x 7 mg + 1 x 8 mg + 1 x 9 mg + 3 x 10 mg)EUR 313.78
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Ponésimod in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomPonvory 2mg tabletsJuvise Pharmaceuticals
- NorwayPonvoryLABORATOIRES JUVISE PHARMACEUTICALS
- SwitzerlandPonvory 10 mg, FilmtablettenMedius AG
- CzechiaPONVORYLaboratoires Juvisé Pharmaceuticals, Villeurbanne
- United StatesPONVORYVanda Pharmaceuticals Inc.
- SpainPONVORY 2, 3, 4, 5, 6, 7, 8, 9 y 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULALaboratoires Juvise Pharmaceuticals
- FinlandPonvoryLaboratoires Juvise Pharmaceuticals
- NetherlandsPonvory 2 mg + 3 mg + 4 mg + 5 mg + 6 mg + 7 mg + 8 mg + 9 mg + 10 mg filmomhulde tablettenLaboratoires Juvise Pharmaceuticals
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Ponvory
- Liechtenstein · Ponvory
- Norway · Ponvory
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/372e5581-aea4-4d44-bb1b-b81321490b11 GET /v1/drugs/372e5581-aea4-4d44-bb1b-b81321490b11?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "61715282",
"date_amm": "2021-05-19",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/21/1550",
"substance": "PONÉSIMOD",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé(s)",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about ponésimod.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.